ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 2039 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 2039; 2) Community: the network communities that were significantly associated with the response to NSC 2039; 3) Molecule: the relationships between components within communities and NSC 2039; 4) MDR: the compounds that were significantly associated with the NSC 2039.

NSC Compound Enrichment Correlation
NSC 695935 Null 0.00838963112864931 0.30024556
NSC 700136 Null 0.00838963112864931 0.28915124
NSC 705305 Null 0.00838963112864931 0.26685856
NSC 708062 Null 0.00838963112864931 0.37709116
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.00838963112864931 0.28782888
NSC 758682 ARTENIMOL 0.00838963112864931 0.3394344
NSC 89822 Null 0.00838963112864931 0.2211256
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.00838963112864943 0.3705434
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.00838963112864943 0.42996055
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.00841144976667928 0.36440452
Total:80  Current:23    [First] [Prev] [Next] [Last]